Compoz

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Compoz

Quick Facts

  • Active Ingredient: Diphenhydramine hydrochloride
  • Drug Class: First-generation antihistamine
  • Primary Use (OTC): Relief of occasional sleeplessness (insomnia)

Compoz is an over-the-counter (OTC) medication primarily marketed as a nighttime sleep aid. Its active ingredient is diphenhydramine hydrochloride, which belongs to a class of drugs called first-generation antihistamines.

Diphenhydramine works by blocking the action of histamine, a natural substance in the body. While its primary medical use as an antihistamine is to relieve symptoms of allergies, such as sneezing, runny nose, and itching, this same mechanism of action causes a significant side effect: drowsiness. This sedative effect is what is utilized when the drug is repurposed and marketed for the short-term treatment of occasional sleeplessness.

As a sleep aid, Compoz is intended for use by adults and children 12 years of age and older. However, it is generally recommended by medical professionals for short-term use only, and long-term use for insomnia is not typically advised. Patients should carefully review the full list of active and inactive ingredients and consult a healthcare provider to ensure safe use, especially to avoid taking multiple products that contain diphenhydramine.

What side effects are possible with Compoz?

Possible side effects and safety information

Regulatory Safety Profile

Official regulatory documents classify the safety profile of Compoz, which contains diphenhydramine hydrochloride, primarily based on its effects on the Central Nervous System (CNS) and its anticholinergic properties. The most frequent and common adverse reactions include sedation, sleepiness, dizziness, disturbed coordination, fatigue, and dryness of the mouth, nose, or throat. These effects typically represent the high-level expected characteristics of this drug class.


System-Organ Classes and Less Common Effects

Adverse reactions are formally grouped by the body systems they affect, including the Nervous System, Gastrointestinal System, Eye Disorders, Cardiovascular System, and Renal/Urinary System. Less frequent, documented adverse effects listed in regulatory labeling include restlessness, confusion, blurred vision, tinnitus, and nausea. Rare, but officially documented serious adverse reactions include anaphylactic shock and certain hematologic disorders such as agranulocytosis and hemolytic anemia.


Population-Specific Safety and Restrictions

Safety labeling explicitly notes differing risks for specific populations. Older adults (60 years and older) are documented as being more susceptible to certain effects, including dizziness, sedation, and hypotension. Use in the third trimester of pregnancy and by nursing mothers is generally restricted or contraindicated in official labeling. Furthermore, the drug is restricted or advised to be used with considerable caution in individuals with certain pre-existing conditions, such as narrow-angle glaucoma, symptomatic prostatic hypertrophy, or specific obstructive gastrointestinal conditions.

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

The official regulatory profile for diphenhydramine overdose details a broad spectrum of toxicity, primarily affecting the Central Nervous System (CNS) and the cardiovascular system. An overdose may present with signs of both CNS depression, such as excessive sleepiness and coma, and CNS stimulation, including agitation, delirium, hallucinations, and seizures.

Documented Manifestations and Risks

Anticholinergic signs, such as mydriasis (fixed, dilated pupils), dry mouth, flushing, tachycardia (rapid heart rate), and urinary retention, are officially documented. Severe and life-threatening outcomes include the potential for serious cardiac arrhythmias, QRS widening, QTc prolongation, and cardiac arrest. Overdosage may also lead to convulsions, coma, and death. In pediatric patients, CNS stimulation and convulsions are specifically noted as more likely, while elderly patients may experience a greater risk of sedation and hypotension.

Required Emergency Action

Immediate medical attention must be sought when specific, severe manifestations occur. Regulatory guidance requires contacting emergency services immediately if the individual collapses, has seizures, has trouble breathing, cannot be awakened, or is hallucinating.

No specific antidote is known for diphenhydramine toxicity, confirming that management is symptomatic and supportive. Administration of activated charcoal is a documented procedure. Continuous monitoring, including an Electrocardiogram (ECG), is a requirement for observation due to the risk of severe cardiotoxicity. Stimulants are explicitly contraindicated in treatment.

Therapeutic Uses of Compoz

Compoz is commonly used to provide supportive symptomatic relief for temporary sleep disturbances, focusing strictly on easing the symptoms that interfere with the ability to rest. Its active ingredient is recognized for use in the relief of occasional sleeplessness within the context of over-the-counter (OTC) sleep aids.

Managing Difficulty Falling Asleep

Compoz is applied in addressing symptomatic patterns such as difficulty initiating sleep, which may manifest as restlessness or the inability to quiet the mind when trying to go to bed. This therapeutic approach may assist with promoting drowsiness to help facilitate sleep onset. It is commonly used when short-term symptomatic assistance is needed, offering supportive relief that helps patients cope more steadily with difficult nights and supports the maintenance of functional stability during symptomatic periods. The medication may be relevant in scenarios such as sleep difficulty associated with temporary situational stress, changes in routine, or minor issues like jet lag.


Quick Fact

Quick Fact: Relief for Occasional Sleeplessness (Relevant for symptoms of difficulty initiating sleep and temporary nocturnal restlessness.)

Eligibility and Restrictions for Use

The official eligibility profile for Compoz (diphenhydramine) is defined by strict Contraindications and specific restrictions tied to age, pre-existing health conditions, and physiological status.

Contraindications and Exclusions

Classification Population/Condition
Absolutely Prohibited Neonates or Premature Infants
Absolutely Prohibited Nursing Mothers (due to risk to the infant)
Absolutely Prohibited Individuals with known Hypersensitivity to diphenhydramine
Condition-Based Exclusion Acute asthma attacks or lower respiratory tract symptoms

Age-Related Eligibility and Caution

Over-the-counter use as a nighttime sleep aid is Contraindicated for children under 12 years of age. For individuals 60 years or older, the medicine should be used with considerable caution as they are more likely to experience strong side effects such as sedation, dizziness, and hypotension.

Restricted Use (Caution Required)

Individuals with the following conditions should use Compoz only if specifically directed by a healthcare professional:

  • Glaucoma (particularly narrow-angle)
  • Difficulty in urination due to enlargement of the prostate gland or bladder-neck obstruction
  • Stenosing peptic ulcer or pyloroduodenal obstruction
  • A breathing problem such as emphysema or chronic bronchitis

Use during Pregnancy should occur only if clearly needed. The regulatory profile restricts the use of Compoz to adults and children over 12 years who do not possess any of the documented contraindications or high-risk caution factors.

What should I know about interactions with other medicines?

Compoz Interactions with other medicines and products

Compoz, which contains the active ingredient diphenhydramine, an antihistamine, has a documented interaction profile centered on its additive effects with other substances that cause central nervous system (CNS) depression or share anticholinergic properties.


Potential Drug and Substance Interactions

Interacting Category Mechanism/Effect Regulatory Constraint
Alcohol May increase drowsiness and sedation. Avoid alcoholic beverages.
Sedatives/Tranquilizers Combined effect may increase drowsiness/sleepiness. Consult a doctor or pharmacist.
Prescription Drugs for Depression May increase sedation and other side effects. Consult a doctor or pharmacist.
Prescription Drugs for High Blood Pressure May increase the risk of side effects. Consult a doctor or pharmacist.
Other Anticholinergics May increase side effects such as dry mouth, confusion, and difficulty urinating. Caution advised.

General Interaction Guidance

The primary concern when using this product is the potential for increased drowsiness when combined with alcohol, sedatives, tranquilizers, and certain prescription medications. This is due to a summation of effects on the central nervous system. Before using Compoz, it is necessary to consult a healthcare professional if you are currently taking any prescription drug for high blood pressure or depression, or any sedatives or tranquilizers. Furthermore, the official labeling strictly advises against the consumption of alcoholic beverages while taking this product to mitigate the risk of excessive sedation and impaired alertness.

Mechanism of Action

The mechanism of action is defined by the engagement and modulation of two primary neural signaling systems, resulting in a reduction in central nervous system (CNS) activity.


Central Arousal Modulation: H₁ Receptor Antagonism

This mechanism focuses on the Histamine H₁ Receptors that mediate the CNS pathways of wakefulness. By acting as a competitive antagonist, the drug blocks the natural signaling of histamine, a key neurotransmitter that promotes alertness. This action suppresses the Ascending Reticular Activating System (ARAS), which is instrumental in maintaining arousal. The resulting physiological effect is a rapid onset of CNS depression.


Dual-System Dampening: Cholinergic Modulation

The primary action is concurrent with a potent secondary mechanism: the antagonism of Muscarinic Acetylcholine Receptors (mAChR). This dual activity on both the histaminergic and cholinergic pathways contributes to the overall dampening of excitatory neural activity in the brain. The cholinergic modulation further contributes to the generalized reduction in CNS function.


Mechanistic Constraints: Tolerance and Variability

The core mechanism is constrained by the rapid development of functional tolerance, where the targeted pathways adapt to the H1 receptor blockade following repeated exposure. The mechanism is also subject to genetic variability in drug metabolism via the CYP2D6 enzyme, which can lead to variable CNS concentrations, resulting in variable effects, including reduced CNS depression or, in rare cases, paradoxical central excitation.

Dosage and Administration Information

The administration of Compoz (diphenhydramine hydrochloride) as an over-the-counter nighttime sleep aid is provided in the following instructions.

Administration Guidelines

The following table outlines the standardized use parameters based on product labeling.

Usage Parameter Instruction
Route & Dosage Oral administration only. The standard single dose is 50 mg of diphenhydramine hydrochloride.
Frequency & Timing The product is taken once daily at bedtime, as needed for occasional sleeplessness. It should be taken approximately 20 to 30 minutes before sleep.
Maximum Dose No more than one dose (50 mg) should be taken in any 24-hour period.
Duration of Use For short-term use only. The product should be discontinued if sleeplessness persists continuously for more than two weeks.

Administration Requirements

Compoz is intended for use by adults and children 12 years of age and older, and is not to be given to younger children for this purpose. Solid dosage forms, such as capsules or tablets, are generally instructed to be swallowed whole. Liquid formulations require the use of a provided measuring device for accurate dosing. The timing of administration may be with or without food.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Compoz

Evidence for Use in Occasional Sleeplessness

Research examining Compoz has primarily focused on the indication of occasional sleeplessness, a condition associated with acute or disruptive episodes. The studies conducted have mainly been short-term Randomized Controlled Trials (RCTs) and used in observational settings evaluating daily-life functioning, which are common study types for this kind of medication. These trials research examined outcomes related to sleep latency (the time it takes for a person to fall asleep) and total sleep time. The populations was studied for conditions where symptoms may vary in intensity.

Studies monitored and described measurements of sleep latency and total sleep time in the participants over the observation period. Research highlights changes measured during the study period in these key metrics. These trials often observe responses over defined time intervals, and studies monitored how individuals reported their sleep quality. The evidence contributes to the broader evidence landscape, but it is important to remember that these findings describe group patterns, not personal outcomes.

Head-to-Head and Comparison Study Designs

In research settings, Compoz was evaluated in studies designed to compare it against a non-active agent, often called a placebo, to understand outcomes related to systemic or functional imbalance. Researchers also studies explored how it performed against control conditions. Studies designed for comparison reported measurements related to sleep in the observed populations.

Comparative evidence against control treatments is not consistent across all studies, and research against other compounds is limited. Evidence suggests that the observed patterns often relate to the specific conditions under which the studies were conducted.

Long-Term Studies and Follow-up

Most of the available research and the main RCTs for Compoz research exploring short-term symptom changes have follow-up durations were limited, typically lasting only a few days to a couple of weeks. This means there is limited information for long-term outcomes regarding continued use.

Long-term effects are not fully established. Evidence is limited regarding the durability of the compound’s effects beyond the short-term administration period. Also, data concerning the patterns that emerge after use is discontinued is often not a central focus of these trials. Information about usage patterns in observational settings over extended periods is still being compiled.

Evidence in Special Populations

Compoz was studied for adults, and the results apply only to the populations studied. Data for certain groups remain insufficient. For example, research describing use in adolescents is limited.

Research examined differing patterns of observed study outcomes in some studies involving older adults (geriatric populations). However, these studies often have modest sample sizes, and information for specific subgroups remains limited. Data are still emerging regarding its use in people with specific comorbid conditions (other existing health issues), and these specific contexts are often not the primary focus of the initial efficacy trials.

Strength and Limitations of the Evidence

Overall, the evidence quality varies across studies available for Compoz. While short-term RCTs contribute to the broader evidence landscape, these trials often suffer from modest sample sizes and limited follow-up durations. The research provides context but not individual predictions.

Certainty remains low in areas such as long-term use and outcomes in highly specific populations. The evidence is limited to the specific conditions and populations examined in the trials. The evidence contributes to understanding the knowns and unknowns of the research.

Key Studies & References

  1. Efficacy and safety of diphenhydramine in the treatment of transient insomnia in adults: A short-term, randomized, placebo-controlled trial

Frequently Asked Questions (FAQ)

Common questions about Compoz (FAQ)

Q: How long do the typical effects of Compoz usually last in the body?

Regulatory instructions state that this product is to be taken once daily at bedtime for occasional sleeplessness. This usage pattern indicates that the product is designed to function as a nighttime sleep aid. Official guidance on administration is centered on its function as a nightly product.


Q: Is there a risk of interaction if Compoz is combined with over-the-counter cold and flu medicines?

Official drug labels caution against using this product with any other medicine containing its active ingredient, diphenhydramine. This warning is in place because combining products can lead to excessive amounts of the ingredient in your system, increasing the risk of over-sedation or serious side effects.


Q: What are the signs of a severe reaction to Compoz?

Regulatory documents contain warnings to discontinue use and seek immediate medical assistance if symptoms like trouble breathing, inability to be awakened, or new skin symptoms (blisters, rash, swelling) occur. The warnings relate to the need for prompt medical attention if severe symptoms occur.


Q: Why is it important to check if other medicines contain diphenhydramine or similar antihistamines?

This check is critical because taking multiple medicines that contain diphenhydramine, or similar ingredients that cause sleepiness, increases the risk of serious adverse effects. The official warnings aim to prevent unintentional overdose, which can lead to excessive drowsiness, seizures, coma, or death. Regulatory labels strictly advise against exceeding the maximum recommended dosage.


Q: How can I check for potential interactions before taking Compoz with another drug?

Official drug labels indicate that consultation with a doctor or pharmacist is necessary before use if you are currently taking sedatives, tranquilizers, or any drug that causes drowsiness. This consultation is indicated for checking and managing potential interactions.


Q: Are there any known long-term effects associated with using Compoz?

Regulatory documents state that Compoz is intended for short-term use only. Official labeling advises discontinuation and consultation with a healthcare professional if sleeplessness persists continuously for more than two weeks. This is because ongoing insomnia can be a symptom of a more serious underlying medical illness.


Q: Does the drowsy feeling from Compoz usually lessen over time?

Scientific understanding of the drug's mechanism notes that functional tolerance can develop with continued use. This suggests that the body's systems may adapt to the blockade over time.


Q: What kind of research has been conducted to support the use of Compoz for sleep?

Studies supporting its use typically include short-term trials focused on improving sleep outcomes, such as measurements of sleep latency and total sleep time. These findings contribute to the overall evidence base for the product's intended use.


Q: Does Compoz have a risk of misuse or overdose?

Regulatory agencies have issued warnings that taking doses higher than recommended can lead to serious problems, including severe heart issues, seizures, coma, or death. Official guidance emphasizes that the product must be used only as directed on the label.


Q: Why is Compoz used as a sleep aid if its active ingredient is also for allergies?

The active ingredient works as an antihistamine, blocking the chemical histamine. Since histamine promotes wakefulness in the brain, blocking it causes the side effect of drowsiness. This sedative effect is the primary action utilized when the drug is marketed as a nighttime sleep aid.


Q: Does Compoz treat other symptoms besides sleeplessness?

According to the official uses section of the label, the active ingredient is also indicated to temporarily relieve symptoms of hay fever or other upper respiratory allergies. These symptoms include common issues like sneezing, runny nose, and itching of the eyes or throat.


Q: What is the difference between Compoz and a non-drowsy allergy medicine?

Compoz’s active ingredient acts on the central nervous system (CNS) to cause drowsiness, which makes it suitable as a sleep aid. Conversely, non-drowsy allergy medicines are designed to limit the extent to which they cross the blood-brain barrier, thereby minimizing central nervous system effects and preserving wakefulness.


Q: Is daytime grogginess or a 'hangover' feeling a common expectation when using Compoz?

Regulatory documents list common side effects that include sedation, sleepiness, and dizziness. These effects may persist into the following day and can negatively affect a person's ability to drive or operate machinery.


Q: Can Compoz cause constipation or trouble emptying the bladder?

Official adverse effect listings include constipation as a common side effect. The product is also restricted for individuals with difficulty urinating, as this condition is listed as a caution factor.


Q: Is it possible to feel agitated or restless after taking Compoz?

Official adverse reaction reports note that agitation, restlessness, or confusion can be less common effects. In certain cases, especially with use in children, the drug may lead to paradoxical central excitation, meaning it causes a stimulating or excitable effect instead of drowsiness.


Q: Why might Compoz cause blurry vision?

Blurry vision is known as an anticholinergic side effect, which is related to the drug's action on specific nerve receptors in the body. This action can affect the muscles that control the focus of the eye.


Q: Can Compoz be used with common pain relievers like ibuprofen or acetaminophen?

While the active ingredient is sometimes found in combination products, official guidance includes cautions about combining the product with other medications. A healthcare professional should be consulted prior to use in combination with these.


Q: Does Compoz interact with common heart or blood pressure medications?

Official product labels advise consulting a doctor or pharmacist if you are currently taking any prescription drug for high blood pressure, as combining medications may increase the risk of side effects. Additionally, an overdose of the active ingredient is associated with the risk of severe cardiovascular problems.


Q: Are there any specific herbal or dietary supplements that are generally not recommended to take with Compoz?

Official instructions advise consulting a doctor or pharmacist before combining Compoz with other sedatives. This guidance is relevant to any supplement known to cause drowsiness or sleepiness.


Q: Does Compoz interact with any foods or non-alcoholic beverages?

The regulatory guidance on administration states that the product may be taken either with or without food. No specific food interactions or restrictions with non-alcoholic beverages are cited in the official labeling.


Q: Who is not recommended to use Compoz?

The product is generally not recommended for children under 12 years of age or for nursing mothers. Restrictions are also in place for individuals with certain health conditions, such as narrow-angle glaucoma, difficulty urinating due to prostate issues, or severe breathing problems.


Q: Is Compoz suitable for children or adolescents?

As a nighttime sleep aid, the product is officially indicated for use by adults and children 12 years of age and older. It is contraindicated for use in children under 12 years of age for this purpose.


Q: Can people with liver or kidney issues use Compoz?

Official labeling for similar products advises consulting a doctor before use if you have liver disease. While specific contraindications vary, caution is advised for individuals with these conditions, particularly due to the potential for urinary retention.


Q: Why do older adults sometimes experience more pronounced side effects with Compoz?

Official safety profiles document that older adults (60 years and older) are more susceptible to certain side effects. These more noticeable effects include dizziness, excessive sedation, and low blood pressure (hypotension). The increased susceptibility is often related to physiological changes.


Q: Is there a specific chemical compound in Compoz that makes people feel drowsy?

The product's active ingredient, diphenhydramine hydrochloride, is the compound responsible. Its classification as a first-generation antihistamine means it is the secondary action of central nervous system (CNS) depression that causes the sedative effect.


Q: Is it considered safe to take Compoz if I have a history of seizures or convulsions?

Taking higher than recommended doses of the active ingredient is known to potentially lead to seizures and convulsions. Official safety guidance indicates that caution and consultation with a healthcare professional are necessary for individuals with a history of these conditions.


Q: Do other medications need to be stopped before starting a short-term course of Compoz?

Regulatory guidance indicates that consultation with a doctor or pharmacist is necessary to determine if any prescription or over-the-counter medication should be adjusted or discontinued before taking Compoz. This is especially important for drugs that already cause sleepiness or interact with the active ingredient.


Q: What should a user look for on the label to ensure they are using the product correctly?

Official guidance indicates that consumers should review the Drug Facts label before using the product. Key information to check includes the active ingredients list, the correct single dose, how often to take it, and the important safety warnings, particularly those related to interactions.


Q: Are there different strengths or dosage forms of Compoz available (e.g., tablet, liquid)?

The active ingredient, diphenhydramine, is available in various dosage forms, which are designed for different populations and administration needs. These commonly include solid forms, such as tablets or capsules, and liquid oral solution forms.

How should Compoz be stored and disposed of?

How to Store and Dispose of Compoz?

Official storage and disposal requirements for Compoz are designed to maintain the drug's stability and ensure public safety, based on government regulatory guidance.

Storage Requirements

Condition Requirement (Official Labeling)
Temperature Store at Controlled Room Temperature (20 to 25 C / 68 to 77 F). Do not freeze or expose to excess heat.
Protection Keep in the original, tightly closed container. Protect from moisture and light.
Child Safety Keep the medicine out of the sight and reach of children (a mandatory requirement).

Disposal Instructions

Expired or unused Compoz must be disposed of according to official protocols. The recommended method is to drop off the product at a drug take-back location.

If a take-back program is unavailable, the medicine can be mixed with an undesirable substance (e.g., dirt) and placed in a sealed bag for disposal in the household trash, following FDA guidelines. Importantly, the product must not be thrown away via wastewater or flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Compoz found in:

A-Z Index: